Clinical Trials Update: Oct. 14, 2004

Erectile Dysfunction Bladder Disorders Fibrocystic Breast Disease

By HealthDay News HealthDay Reporter

Updated on June 14, 2022

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Erectile Dysfunction

A research study of an investigational medication for erectile dysfunction. Volunteers 18-65 who have a clinical diagnosis of erectile dysfunction of at least six months, have had successful response to another approved treatment for a minimum of two months, and are in a stable relationship may be eligible. Research site located in Salt Lake City, UT.

More Information

Please see http://www.centerwatch.com/patient/studies/cat371.html.

-----

Bladder Disorders

A research study examining an investigational medication for overactive bladder. Volunteers 18 and older who had had symptoms including urge incontinence, frequency, and urgency for at least six months may be eligible. Research site located in Las Vegas, NV.

More Information

Please see http://www.centerwatch.com/patient/studies/cat445.html.

-----

Fibrocystic Breast Disease

A research study of an investigational medication to treat symptoms of fibrocystic breast disease. Otherwise healthy women ages 18 to 50 who are experiencing fibrocystic breast tenderness and pain may be eligible. Research site located in Chicago, IL.

More Information

Please see http://www.centerwatch.com/patient/studies/cat392.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ